Global Health Limited (NSE:MEDANTA)
India · Delayed Price · Currency is INR | Market Cap | 387.15B +21.7% |
| Revenue (ttm) | 50.53B +26.2% |
| Net Income | 6.18B +10.1% |
| EPS | 22.96 +9.9% |
| Shares Out | 268.87M |
| PE Ratio | 62.71 |
| Forward PE | 45.20 |
| Dividend | 0.50 (0.03%) |
| Ex-Dividend Date | Aug 14, 2026 |
| Volume | 220,199 |
| Open | 1,435.90 |
| Previous Close | 1,429.00 |
| Day's Range | 1,431.30 - 1,454.70 |
| 52-Week Range | 956.00 - 1,544.00 |
| Beta | 0.23 |
| Analysts | Strong Buy |
| Price Target | 1,652.16 (+14.74%) |
| Earnings Date | Nov 3, 2026 |
About Global Health
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and d... [Read more]
Financial Performance
In fiscal year 2026, Global Health's revenue was 44.10 billion, an increase of 19.44% compared to the previous year's 36.92 billion. Earnings were 5.56 billion, an increase of 15.58%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for MEDANTA stock is "Strong Buy." The 12-month stock price target is ₹1,652, which is an increase of 14.74% from the latest price.
News
Global Health Transcript: Q2 26/27
Q2 revenue grew 34% and operating EBITDA 60% YoY, while Noida reached EBITDA breakeven. Expansion plans target over 7,600 beds, backed by more than INR 6,000 crore of planned capex over 4–5 years.
Global Health Quarterly report: Q2 2027
Global Health has published its Q2 2027 quarterly earnings report on November 4, 2026.
Global Health Slides: Q2 2027
Global Health has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on November 4, 2026.
Global Health Transcript: Q1 26/27
Q1 FY 2027 delivered strong 26% revenue growth and 23% EBITDA growth, driven by robust patient volumes and operational efficiency. Noida's EBITDA loss narrowed sharply, and expansion plans remain on track with a significant pipeline. Demand tailwinds and disciplined execution support a positive outlook.
Global Health Quarterly report: Q1 2027
Global Health has published its Q1 2027 quarterly earnings report on July 31, 2026.
Global Health Slides: Q1 2027
Global Health has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on July 31, 2026.
Medanta block deal: 10 lakh shares worth Rs 122 crore change hands in pre-open window
Shares of Global Health Ltd, which operates Medanta hospitals, remained largely steady in early trade on Monday, May 25, after a block deal involving 10 lakh shares was executed in…
Global Health Transcript: Q4 25/26
Strong year-on-year growth in revenue, EBITDA, and patient volumes, with robust expansion across mature and developing hospitals. Noida hospital ramp-up is progressing, with breakeven expected in the second half of FY 2027. CapEx plans remain disciplined, supported by a solid net cash position.
Global Health Quarterly report: Q4 2026
Global Health has published its Q4 2026 quarterly earnings report on May 15, 2026.
Global Health Slides: Q4 2026
Global Health has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 15, 2026.
Global Health Annual report: Q4 2026
Global Health has published its Q4 2026 annual report on May 15, 2026.
Medanta Expands Indore Presence with Takeover of 80 Bed Cancer Hospital
GURUGRAM, India, April 27, 2026 /PRNewswire/ -- Global Health Limited 'Medanta', one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, to...
Medanta to invest Rs 550 crore in new 400-bed hospital in Varanasi
Global Health Limited, operating under the brand Medanta, has announced plans to establish a 400-bed multi-specialty hospital in Varanasi, Uttar Pradesh. The decision was made during a board meeting h...
Global Health Transcript: Q3 25/26
Q3 FY 2026 delivered 19% year-on-year income growth, with strong EBITDA margins and robust expansion, especially in Noida and developing hospitals. Margin pressures stemmed from early-stage losses and higher employee costs, but outlook remains positive with ongoing network growth and tariff improvements.
Global Health Quarterly report: Q3 2026
Global Health has published its Q3 2026 quarterly earnings report on February 5, 2026.
Global Health Slides: Q3 2026
Global Health has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 5, 2026.
Global Health Q3 Results: Net profit falls 33.6% YoY to Rs 95 crore, revenue up 18.8% YoY
Global Health Limited, the company operating the Medanta hospital chain, reported a mixed set of Q3 results, with strong revenue...
Global Health Transcript: Q2 25/26
Q2 FY 2026 saw 15% YoY revenue growth, 21% PAT growth, and strong cash flows, driven by robust performance in both mature and developing hospitals. Noida Hospital commenced operations, and major expansion projects in Guwahati and Mumbai are underway. Talent retention remains strong, with industry-wide RPOP growth moderating.
Global Health Quarterly report: Q2 2026
Global Health has published its Q2 2026 quarterly earnings report on November 10, 2025.
Global Health Slides: Q2 2026
Global Health has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 10, 2025.
Global Health Transcript: Q1 25/26
Q1 FY 2026 saw record income and EBITDA, with 19% revenue and 50% PAT growth year-on-year, driven by higher patient volumes and operational efficiency. Expansion continues with new hospitals in Ranchi and Noida, and a strong cash position supports future growth and acquisitions.
Global Health Quarterly report: Q1 2026
Global Health has published its Q1 2026 quarterly earnings report on August 8, 2025.
Global Health Slides: Q1 2026
Global Health has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 8, 2025.
Global Health share jumps over 4% on strong Q1 earnings; profit rises nearly 50% YoY
Shares of Global Health Ltd, which operates under the Medanta brand, rose 3.72% to ₹1,376.40 in early trade on Thursday after the company posted robust earnings for the June quarter. In Q1FY26 (consol...
Medanta opens new 110-bed hospital in Ranchi, expands capacity
Global Health Limited, which operates hospitals under the Medanta brand, announced the commencement of operations at its newly constructed hospital in Ranchi today. As per the company’s filing with BS...